Our Services
Others
- DFPP
- Shockwave
- IV Drip
Parkinson’s disease is a long-term, progressive neurological disorder that interferes with movement, coordination, and overall physical control. It occurs when nerve cells in a region of the brain called the substantia nigra begin to deteriorate. These specialized neurons produce dopamine, a neurotransmitter that helps regulate muscle movement and communication within the nervous system. As dopamine levels decline due to neuronal loss, individuals start to develop classic motor symptoms such as tremors, stiffness, slowed movement, impaired balance, and difficulty initiating physical actions. Over time, these symptoms can intensify and interfere with daily activities.
In addition to motor challenges, people with Parkinson’s often experience a variety of non-motor symptoms. Fatigue, sleep irregularities, mood changes, cognitive difficulties, and reduced motivation can all accompany the disease, affecting independence and emotional well-being. With its wide-ranging impact on physical and mental function, Parkinson’s disease remains one of the most challenging neurological conditions to manage.
Current Treatment Options and Their Limitations
Traditional treatments for Parkinson’s disease are primarily designed to replace dopamine or enhance its activity in the brain. The most commonly prescribed medication, levodopa, can significantly improve movement when taken consistently. Other drugs, such as dopamine agonists and MAO-B inhibitors, also help regulate symptoms in the early and middle stages of the disease. While these therapies can provide meaningful relief, they do not stop the degeneration of dopamine-producing neurons.
As time passes, medications may lose their effectiveness, requiring higher doses or more frequent administration. Many patients also develop complications such as dyskinesias—uncontrolled, involuntary movements caused by long-term medication use. Because current treatments primarily manage symptoms rather than address the underlying cause of neuronal loss, researchers and clinicians have been exploring regenerative therapies that may restore function more directly. One of the most promising approaches involves the use of mesenchymal stem cells derived from umbilical cord tissue.
Why Stem Cells Hold Therapeutic Potential
Mesenchymal stem cells (MSCs) are a special type of stem cell capable of renewing themselves and transforming into different types of tissues, including neural cells. Umbilical cord–derived mesenchymal stem cells (UC-MSCs) have become a leading candidate for neurological regenerative therapies because they are biologically young, highly active, and collected safely from donated umbilical cords following healthy births. Their naturally low risk of triggering an immune response makes them a suitable option for clinical use.
In the treatment of Parkinson’s disease, UC-MSCs may support the repair of damaged neural pathways and contribute to restoring dopamine production. Instead of simply masking symptoms, these cells aim to encourage the brain to recover and maintain healthier function over time.
How Stem Cell Therapy May Help in Parkinson’s Disease
Benefits of Stem Cell Therapy for Individuals with Parkinson’s Disease
Why Thailand Is Emerging as a Leader in Regenerative Therapies
Thailand has become a preferred destination for stem cell–based treatments due to its advanced medical infrastructure and growing expertise in regenerative medicine. Clinics and hospitals across the country offer modern facilities, specialized laboratories, and teams of trained professionals who focus on stem cell research and clinical application.
Patients seeking stem cell therapy in Thailand benefit from:
Thailand’s strong biotechnology sector and commitment to responsible clinical practice have positioned the country at the forefront of stem cell innovation in Asia.